ja36 v1-0 13apr10 w501 final slides day 1

Upload: suman-amin

Post on 04-Apr-2018

222 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    1/162

    International Module W501

    Measurement of Hazardous Substances

    (including Risk Assessment)

    Day 1

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    2/162

    Insert site Emergency procedures

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    3/162

    Insert Lecturer(s) Background

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    4/162

    Your Background?

    Two (2) minute overview of your background

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    5/162

    Course Aims

    To provide participants with a sound understandingof the techniques for assessing exposure tohazardous substances in the workplace

    To understand how exposure information can beused to assess risk

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    6/162

    Course Learning Outcomes

    Participants will be able to:

    Describe the general approach to occupational health riskassessment including role of atmospheric monitoring

    Select the appropriate equipment to measure specificairborne contaminants & devise a suitable samplingstrategy

    Present the results in a useful form

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    7/162

    What is Required to Complete this Course

    Ask questions as we go through the notes

    Participate in the case study discussions

    Participate in the practical exercises

    Attempt the questions each night

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    8/162

    What is Occupational Hygiene ?

    'Occupational Hygiene is the discipline of

    anticipating, recognising, evaluating and

    controllinghealth hazardsin the working

    environment with the objective ofprotecting

    worker healthand well-being and safeguarding

    the community at large.'

    (Source IOHA)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    9/162

    Topics to be Discussed

    Basic physiology & toxicology

    Risk assessment

    Hygiene standards

    Air sampling theory & practice

    Biological monitoring Sample analysis

    Dusts, fumes & fibres

    Vapours & gases

    Presentation of results

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    10/162

    Todays Learning Outcomes

    Physiology & toxicology

    Understand and be aware of the features of theinteracting systems of the human body

    Understand the routes of contaminant entry intothe human body and their target organs andsystems

    Understand the concept of dose response

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    11/162

    Todays Learning Outcomes (cont)

    Risk Assessment

    Understand principles & processes of riskassessment

    Be able to apply these principles & processes in aworkplace situation

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    12/162

    Todays Learning Outcomes (cont)

    Hygiene standards

    Understand the principles of setting hygiene

    standards

    Understand the application and limitations ofhygiene standards

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    13/162

    Work Groups

    Each participant will be assigned a work group forthe duration of the course

    The work groups are expected to work as a teamwhen evaluating cases studies and undertakingpractical sessions

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    14/162

    Introduction to Physiology & Toxicology

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    15/162

    Discussion Topics

    The Human Body

    Routes of Entry

    Target Organs & Systems

    Concept of Dose Response

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    16/162

    The Human Body

    12 Interacting systems:

    Cardiovascular Muscular

    Digestive Nervous

    Endocrine Reproductive

    Immune Respiratory

    Integumentary Skeletal

    Lymphatic Urinary

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    17/162

    Cardiovascular System

    Includes the heart, blood & the blood vessels(arteries, capillaries & veins)

    Arteries bring oxygenated blood from heart to the

    tissues

    Veins bring deoxygenated blood back to the heart

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    18/162

    Digestive System

    Takes in food, digests it & extracts energy &nutrients & expels the waste

    Nutrients can be absorbed into blood & lymph

    systems

    Some used for energy, some for building tissues &

    cells & some stored for future use

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    19/162

    Endocrine System

    Control system of glands which secrete chemicalmessengers or hormones

    Endocrine glands release hormones directly intobloodstream of the body

    Regulate metabolism, growth & sexual development

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    20/162

    Immune System

    Protects body from infection by creating &maintaining barriers to prevent that bacteria &viruses entering the body

    e.g. hepatitis, influenza, cholera, typhoid & malaria

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    21/162

    Integumentary System

    Comprises skin (cutaneous

    membrane) & hair, nails &

    endocrine glands

    epidermis

    dermis

    subcutaneous tissue

    Largest organ of body

    interface with surroundings

    Insulation & temp regulation

    L h ti S t

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    22/162

    Lymphatic System

    Major component of immune system

    Complex system of lymphoid organs, lymph ducts &lymph vessels that produces & transport lymph fluid

    from tissues to circulatory system

    Removal of excess fluids from body tissues

    Absorption of fatty acids & transport of fat tocirculatory system

    Production of immune cells e.g. lymphocytes,monocytes & antibody producing plasma cells

    M l S t

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    23/162

    Muscular System

    Muscle attached to bone by tendons & other tissues

    Exerts force by converting chemical energy into force

    Nerves link muscle to CNS

    Function

    Produce movement

    Maintain posture

    Stabilise joints

    N S t

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    24/162

    Nervous System

    Electrical impulses carried along nerve cells

    CNSbodys control centre

    PNS all other nerves & neurons

    Somatic :

    bodys movement & conscious control

    Autonomic:

    Sympathetic responds to impending danger or stress

    Parasympathetic evident when resting relaxed

    Reprod cti e S stem

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    25/162

    Reproductive System

    Produces offspring by fertilisation or fusion of asperm and one ovum and the subsequentdevelopment of the offspring

    R i t S t

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    26/162

    Respiratory System

    Responsible for carrying oxygen from inhaled air tothe bloodstream & expelling the waste product of

    carbon dioxide

    Skeletal System

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    27/162

    Skeletal System

    206 bones joined by ligaments & tendons Protective & supportive framework for attached

    muscles & soft underlying tissues

    Produces red & white blood cells in bone marrow Bones store minerals eg calcium & can be

    transported elsewhere

    Urinary System

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    28/162

    Urinary System

    The bodys filtering system via the kidneys which

    reabsorb approx 99% of the fluid into the blood

    Waste or urine passed to the bladder for excretion

    Routes of Entry

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    29/162

    Routes of Entry

    Inhalation

    By far most common route of entry

    Skin absorption

    Via direct contact major source of entry oforganics eg solvents and pesticides

    Routes of Entry (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    30/162

    Routes of Entry (cont)

    Ingestion

    Relatively minor route of accidental

    ingestion or poor personal hygiene

    Eye

    Direct entry point for some solvents and also atrisk by direct contact

    Target Organs & Systems

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    31/162

    Target Organs & Systems

    Upon entry to the body contaminants can have anadverse effect on one or more organs (target organs)

    Respiratory

    Irritant & toxic gases eg Carbon monoxide &

    sulphur dioxide Dusts & fibres eg silica & asbestos

    Blood

    Lead and mercury

    Target Organs & Systems (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    32/162

    Target Organs & Systems (cont)

    Central Nervous System Solvents eg toluene, xylene, MEK

    Polycyclic and polyaromatic hydrocarbons

    Liver

    Alcohols & solvents

    Kidneys

    Selenium, alcohol & sodium compounds

    Target Organs & Systems (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    33/162

    Target Organs & Systems (cont)

    Brain

    Mercury - as mad as a hatter

    Urinary

    Biological agents

    Some metals

    Reproductive

    Lead, organic mercury

    Target Organs & Systems (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    34/162

    Target Organs & Systems (cont)

    Fatty tissues

    Solvents

    Skin

    Acids, alkali

    Epoxy resins

    Skeletal

    Lead

    Benzene

    Target Organs & Systems (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    35/162

    Target Organs & Systems (cont)

    Endocrine Lead, cadmium

    Carbon disulphide

    Concept of Dose Response

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    36/162

    Concept of Dose Response

    No substance is a poison by itself, it is the dose

    that makes a substance a poison

    Paracelsus 154

    Dose Effect Relationship

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    37/162

    Dose Effect Relationship

    For each chemical there is a dose-effect relationship

    Acute (immediate) effects (Irritants, CO)

    Chronic (long-term) effects (Benzene, Asbestos)

    Local effects occur at point of contact

    Systemic effects occur at distant target organs

    Dose Effect relationship (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    38/162

    Dose Effect relationship (cont)

    Factors effecting this relationship include

    Physical state of the material

    Concentration

    Possible routes of entry to the body

    Target organs

    Dose Effect Relationship (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    39/162

    Dose Effect Relationship (cont)

    Retention rate in the body

    Human pre-disposition (pre-existing medicalcondition)

    Individual sensitivity

    Frequency & duration of exposure

    Potency of compound

    Synergistic effects with other compounds

    (e.g. asbestos & smoking)

    Key Factors

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    40/162

    ey acto s

    Dose

    Effect

    Critical organ concentration

    Dose

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    41/162

    The concentration of a substance at the site of effect

    (regard being made for the time which substanceconcentration is maintained)

    Dose = concentration x duration of exposure

    Effect

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    42/162

    Any observable biological change associated with the

    contaminant concerned:

    Should be quantifiable

    Does not need to be an adverse observable effect Certain effects can be beneficial and only become

    adverse if the dose is excessive or remains for acritical period of time

    Critical Organ Concentration

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    43/162

    g

    That concentration beyond which organs exhibit

    some effect

    May not be organ of concentration (eg boneaccumulates lead but critical organ is bonemarrow)

    Target Organs

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    44/162

    g g

    Respiratory system

    Skin

    Eyes

    Blood

    Liver

    Kidneys

    Bladder

    Nervous system

    Dose Effect v Dose Response

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    45/162

    p

    Dose effect: Correlation between dose and themagnitude of effect

    Dose response: Correlation between response of anorgan with estimates of dose

    Threshold

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    46/162

    The dividing line between no-effect and effect levelsof exposure

    For each substance there is a threshold ofintoxication which is usually different for individualsubstances

    Dose Response Curve

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    47/162

    p

    Dose Response Curve

    Source: Tranter 1999Reproduced with permission

    Threshold of Intoxication

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    48/162

    For each substance, no matter how toxic, there existsa dose level called the threshold of intoxication,which the human body is capable of accepting anddetoxifying without injury to itself

    Individual Susceptibility

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    49/162

    p y

    Source: AIOH 2007-Reproduced with permission

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    50/162

    Risk Assessment

    Definitions

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    51/162

    Hazard: potential for a substance to cause harm,injury etc

    Exposure: the ability (or potential) for someone tocome into contact with a substance by breathing itin (inhalation), getting it onto the skin or into theeyes (absorption) or swallowing it (ingestion)

    Definitions (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    52/162

    Risk: likelihood that the substance will causeinjury or illness in the conditions of its use

    Note: the terms risk & hazard are treated solelin relation to chemical (substance) safety and notany broader concept

    The Risk Assessment Process

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    53/162

    Risk management is used in all sectors of the

    political, business & community environment

    Part of our everyday activities (e.g. driving to work)

    Central to OH&S legislation in many countries

    Extends to occupational hygiene hazards (e.g.

    conduct of RA for hazardous substances)

    Key Steps to a Successful Risk Assessmen

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    54/162

    Identify substances in the workplace

    Establish which are hazardous & obtain informationon their properties

    Assess the exposure of workers

    Key Steps to a Successful Risk Assessmen

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    55/162

    Evaluate the risks

    Identify actions

    Document & communicate outcomes to stakeholders

    Information

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    56/162

    Primary sources of information:

    Suppliers MSDS

    Label fixed to product

    What Does an MSDS Tell You?

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    57/162

    Product Name

    Codes, Listings

    Major Uses

    Ingredients

    Physical Characteristics

    Precautions for Use

    Safe Handling and Storage Information

    First Aid/Emergency

    To Be Useful, MSDSs, Must Have

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    58/162

    Issue Date

    Company Details (Not O/Seas)

    Substance Name

    Health Effects/First Aid

    Engineering Controls

    Flammable/Fire & Explosion Hazards

    Storage & Handling

    Spills & Disposal

    What Information Can You Obtain From a MSDS

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    59/162

    Toxic effects

    Safe handling procedures

    Exposure standards

    Control technologies

    Engineering

    PPE

    Reference to other analogous compounds

    What Information Can You Obtain From a Label

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    60/162

    Much less detail than a MSDS but usually Name of compound

    Safety phrases

    Risk phrases

    Pictograms

    Suppliers details & emergency number

    Examples of Risk Phrases

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    61/162

    R26 Very toxic by inhalation

    R27 Very toxic in contact with skin

    R34 Causes burns

    R37 Irritating to respiratory system

    R42 May cause sensitisation by inhalation

    R45 May cause cancer

    Examples of Safety Phrases

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    62/162

    S3 Keep in a cool place S8 Keep container dry

    S15 Keep away from heat

    S22 Do not breathe dust S23 Do not breathe vapour

    S24 Avoid contact with skin

    United Nations - GHS

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    63/162

    GHS - Globally harmonised system of classification an

    labelling chemicals

    Single international system

    Currently being implemented by many countries as

    part of national chemical regulations systems

    Risk & safety phrases will be replaced by hazardstatements

    Projected GHS Benefits

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    64/162

    Enhancement of the protection of human healthand the environment by providing aninternationally comprehensible system for hazardcommunication

    Will provide a recognised framework for thosecountries without an existing system

    Projected GHS Benefits (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    65/162

    Will reduce the need for testing and evaluation ofchemicals, and

    Will facilitate international trade in chemicalswhose hazards have been properly assessed andidentified on an international basis

    GHS Pictograms

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    66/162

    Source: ASCC information sheet

    Other Sources of Information

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    67/162

    Collection Method

    Type of Information

    Interviews of workers,managers and engineers

    TasksWork practicesHealth issuesProcesses

    Exposure controlsMaintenanceEnvironmental agents

    Other Sources of Information (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    68/162

    Interviews of medicaland safety staff

    Health problemsPatterns of problemsWork practices

    Exposure historyEnvironmental agents

    Collection Method Type of Information

    Other Sources of Information (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    69/162

    Records:

    Process standardsStandard operatingproceduresProduction

    PersonnelMedicalEngineeringEnvironmental reportsProcess flow diagrams

    Historic conditions

    Chemical inventoriesUsage amountsTasksWork histories

    Performance ofengineering controlsPast environmentalmonitoring resultsPast biological monitoringresults

    Other Sources of Information (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    70/162

    Governmental and non-

    governmental standards

    Literature

    Current exposure limits

    Proposed exposure limit

    Epidemiological studiesToxicological studies

    Emerging issues

    Walkthrough Survey

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    71/162

    Can provide information that may not be otherwise

    evident

    Involves commencing at the starting point of aprocess and following the various components until

    the end product is reached

    To be useful must involve someone familiar with eacstep of the process

    Basic Information From a Walkthrough Survey

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    72/162

    An understanding of the process

    The number of workers involved

    The materials (including quantities) used orhandled

    Evidence of reactions and any materialtransformations

    Engineering controls in place and theireffectiveness

    Basic Information from a Walkthrough Survey (con

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    73/162

    Housekeeping standards

    Visible conditions at the site (any dusts,mists, etc)

    Possible routes of entry to the body

    Personal protective equipment and its use

    Generation of Hazardous Substances

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    74/162

    May be generated as a result of the process and notby any individual chemical

    Process itself may change the form of a substancemaking it harmful

    Fine dusts from solids Fumes from heating chemicals (ammonia

    compounds)

    Assessing the Risk

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    75/162

    Factors influencing the level of risk

    How much a worker is exposed to a hazardoussubstance (exposure)

    Route of entry to the body (inhalation, skin etc)

    Severity of adverse health effects under conditionsof exposure (hazard)

    Duration and frequency of exposure

    Level of Risk

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    76/162

    As a result of using a hazardous substance without

    controls the level of risk depends upon thecombination of the:

    hazard of that substance under its condition of use

    duration & frequency of exposure

    i.e. Risk = combination of hazard and exposure

    Types of Risk Analysis

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    77/162

    Qualitative analysis

    Uses words to describe magnitude of potentialconsequences and likelihood that thoseconsequences will occur

    Used as a screening activity, where basic analysisis appropriate for decisions or where numericaldata or resources are inadequate for a quantitativeanalysis

    Types of Risk Analysis

    Q tit ti l i

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    78/162

    Quantitative analysis

    Uses numerical values for both consequences &likelihood

    Quality of analysis depends on accuracy &completeness of numerical values and validity of

    models used Consequences may be determined by modelling

    the outcomes of events or extrapolation from paststudies or data

    Process of Risk Analysis

    Assessing the risk requires a judgment on the

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    79/162

    Assessing the risk requires a judgment on thelikelihood that a hazardous substance will effect

    someones health

    Ask yourself these questions

    How much of the substance is used or produced &

    how could workers be exposed ? Who could be exposed & how often ?

    What are the routes of entry to the body ?

    What are the consequences of exposure ?

    Process of Risk Analysis (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    80/162

    Gathering information to answer previous questions

    Monitor workplace (for quantitative analysis)

    Determine level of risk

    Non Monitoring Approaches

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    81/162

    HSE (UK) COSHH Essentials

    ILO Chemical Control Tool kit

    HSE (UK) COSHH Essentials

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    82/162

    Control banding tool for small to medium sizeenterprises to do risk assessments for chemicals &mixtures of chemicals

    Required information

    Type of task shoveling, drilling

    Hazard classification (using risk & safety phrasesfrom MSDS )

    Volatility or dustiness (from guidance material)

    Amount used- kg,mg,litres,milliliters

    HSE (UK) COSHH Essentials (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    83/162

    System identifies

    Control band (control approach)

    Produces advice on controlling risk from thechemical being used in the task

    Provides written guidance & documentation

    ILO Chemical Control Tool kit

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    84/162

    Very similar to COSHH Essentials

    Does not apply to process dusts or fumes due to thefact that these are not classified by the supplier ofindividual chemicals

    Has general application to many situations indeveloping countries but susceptible groups (childworkers & pregnant women) need to be considered

    Stages of the ILO Chemical Control Toolkit

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    85/162

    Stage 1 Hazard Classification

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    86/162

    Stage 1 Hazard Classification (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    87/162

    Stage 2 How Much is Used

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    88/162

    Stage 3 - Dustiness

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    89/162

    Stage 3 Volatility

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    90/162

    Source: ILO toolkit

    Stage 4 Control Approach

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    91/162

    Source: ILO toolkit

    Stage 5 Task Specific Control Guidance Sheet

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    92/162

    Source: ILO tool

    Stage 5 Task Specific Control Guidance Sheet

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    93/162

    Source: ILO toolkit

    Stage 5 Task Specific Control Guidance Sheet

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    94/162

    Source: ILO toolkit

    Outcomes of a Risk Assessment

    Significant risk

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    95/162

    g

    Exposure is high or the substance used is highlytoxic

    A dangerous reaction with other substancespossible

    Reasonably foreseeable that leaks or spills of ahazardous substance may occur

    Not significant risk

    Actions

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    96/162

    Process of risk evaluation provides a list of risks

    requiring control, often with priorities

    Need to identify a range of possible control options,evaluating them, selecting appropriate control

    options and implementing them in the workplace Control options should be considered as part of

    overall site or process risk management strategy

    Actions (cont)

    Possible control measures (Hierarchy of Control)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    97/162

    Possible control measures (Hierarchy of Control)

    Elimination of the substance

    Substitution of the substance

    Segregation of the substance from workers

    Engineering methods

    Administrative controls

    Personnel protective equipment

    Elimination

    Difficult to achieve in practice

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    98/162

    Difficult to achieve in practice

    production

    quality

    cost

    Some examples preformed components (eliminating dust)

    components that can be clipped, screwed or boltedtogether (eliminating adhesives)

    Substitution

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    99/162

    Use a safer form of the same substance ( e.g. using a

    substance in pellet rather than powder form)

    Use a safer (less hazardous / less volatile) substance /product (e.g. use water based paint rather than oil basedpaint)

    Process modification (e.g. applying a substance with a brushinstead of spraying the substance)

    Segregation (Isolation)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    100/162

    Can be achieved by separating people from a harmfulagent / process by:

    distance

    time

    barriers

    Engineering Controls

    The use of equipment or processes, to prevent ori i i th l f h d h i l t

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    101/162

    minimise the release of hazardous chemical agents

    Options include: automation / robots total enclosure / containment partial enclosure partial enclosure plus local exhaust ventilation local exhaust ventilation general (dilution) ventilation

    Total Enclosure / Containment

    The operator controls the process from outside thel d th h d i t i d It i d

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    102/162

    enclosure, and the hazard is contained. It is used

    when working with; carcinogens

    sensitisers

    materials under high temperature or pressure

    Examples include:

    Pharmaceuticals, chemical plants and refineries

    Closed loop sampling systems

    Laboratory glove boxes

    Partial Enclosure Plus LEV

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    103/162

    Common examples include:

    welding and grinding benches,

    spray paint booths and

    fume cupboards

    General Ventilation Compared to LEV

    General Ventilation LEV

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    104/162

    Draws contaminant awayfrom source

    Reduces level ofcontaminant inhaled by

    employees

    Very effective ifdesigned and usedcorrectly

    Does not removecontaminant at source

    Reduces backgroundlevels by addition of freshuncontaminated air

    Administrative Controls

    Safe systems of work rely heavily on:

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    105/162

    Safe systems of work rely heavily on:

    good management / supervision employee engagement / behaviour

    written rules and procedures

    information, instruction and training

    Simple instruction, allow to cool before opening

    Administrative Controls (cont)

    Formal standard operating procedure (in wriwhich if

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    106/162

    o a sta da d ope at g p ocedu e ( c

    adopted ensures a task is undertaken the right wayevery time

    task analysis,

    in writing,

    training / competence, supervision

    Permit to work

    confined space entry

    Administrative Controls (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    107/162

    Reducing exposure time

    Employee rotation

    Work rest regimes

    Personal Protective Equipment (PPE)

    Head protection Body protection

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    108/162

    Head protection Body protection

    Eye protection Hand protection

    Ear protection Foot protection

    Respiratory protection

    Actions

    Induction & training

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    109/162

    g

    Extent will depend on level of risk Use the information on the hazards and controls obtained i

    the risk assessment to prepare training materials

    Ongoing workplace monitoring

    Required where serious health effects may occur if controlfail

    Statutory requirement for some substances

    Useful to check effectiveness of control measures

    Actions (cont)

    Health surveillance

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    110/162

    May be required when there is an identifiable work relateddisease

    Likely that disease or condition might occur underconditions of work

    Valid techniques for early detection are available

    Emergency procedures & first aid

    Need to match level risk and address potentialconsequences of an uncontrolled release etc

    Records

    Documentation of risk assessments is a fundamentastep in the process

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    111/162

    step in the process

    Needs to be given attention but in some cases isoverlooked once the risk level is established

    Most organisations use the same format to documenrisks no matter their origins - brings familiarity to theprocess ensuring the level of detail required forongoing review is provided in the documentation

    Reasons for Documentation (cont)

    Communication with stakeholders

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    112/162

    Communication with stakeholders

    Evidence of a systematic approach to riskidentification & analysis

    For later review

    Record of risk & develop the organisationsknowledge database

    Reasons for Documentation (cont)

    Documentation for managerial approval &

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    113/162

    Documentation for managerial approval &

    implementation

    To provide an accountability mechanism & tool

    Audit trail

    Share & communicate information

    Management

    The use of prescriptive legislation in many countriesis diminishing

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    114/162

    is diminishing

    Most authorities have moved to a risk basedapproach where the onus is on the employer toestablish the level of risk and manage accordingly

    Covers a broad range of issues including hazardoussubstances

    Statutory authorities produce guidance materialwhich essentially defines minimum standards

    Case Study 1 Risk Assessment

    Super IH Paints

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    115/162

    Super IH Paints

    Source: BP International

    Case Study 1 Risk Assessment

    Paint Manufacturer - vessel cleaning

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    116/162

    Paint Manufacturer - vessel cleaning

    Case Study video together with backgroundinformation

    Comment on what you see and hear. Ask questions

    Determine the information you need to complete arisk assessment on the task of paint vessel cleaning

    Case Study 1 Student Exercise

    Break up into assigned groups

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    117/162

    p g g p

    Critically review the case study video & gatheredinformation

    Attempt to document a risk assessment & makeconclusions about risk

    Determine actions to improve control

    Case Study 1 Student Exercise

    Use lecture notes for guidance and/or discuss with

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    118/162

    Use lecture notes for guidance and/or discuss with

    lecturer if you require clarification

    Time allowed is 60 minutes

    Be prepared to present your assessment in the groupdiscussion period

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    119/162

    Hygiene Standards

    Hygiene Standards

    Hygiene standard:

    The level of exposure via

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    120/162

    The level of exposure, via

    inhalation, that should not cause ill health to a healthy

    adult when exposed to the contaminant

    Other (interchangeable) terms include:

    Threshold limit values

    Exposure standards

    Occupational exposure limits

    Workplace exposure limits

    Background

    Based on no observed adverse effect level

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    121/162

    Seems to be threshold dose

    Epidemiological studies & occupational hygienemeasurements assist to identify this threshold

    Threshold of intoxication accepting & detoxificationwithout injury

    Background (cont)

    Also based on physiological response

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    122/162

    Irritants Asphyxiants

    Anesthetics

    Carcinogens

    Unbearable odour

    Toxic effect

    ACGIH

    Threshold Limit Values TLVs - refer to airborne

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    123/162

    concentrations under which it is believed that nearlyalworkers may be repeatedly exposed, day after day, ove

    a working lifetime, without adverse effects. TLVs are

    developed to protect normal, healthy adults.

    Documentation

    The source publication that provides the critical

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    124/162

    evaluation of the pertinent scientific information anddata with reference to literature sources upon which

    the TLV or BEI is based

    Documentation of Threshold Limit Values for

    Chemical Substances and Physical Agents and

    Biological Exposure Indices

    Three types of TLVs

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    125/162

    TLV - Time Weighted Average (TLV - TWA)

    TLV Short Term Exposure Limit (TWA - STEL)

    TLC Ceiling (TLC - C)

    TLV TWA

    TLV-TWA The TWA concentration for a conventional

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    126/162

    8-hour workday and a 40-hour work week, to which it isbelieved that nearly all workers may be repeatedly

    exposed, day after day, for a working lifetime without

    adverse effect.

    TWA (8-hr) = C1T1 + C2T2 +..CnTn

    8

    Calculate 8-hour TWA

    Working period mg/m3 Duration of sampling (h)

    0800 - 1030 0.32 2.5

    1045 1245 0 07 2

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    127/162

    1045 - 1245 0.07 2

    1330 0.2 2

    1545 1715 0.1 1.5

    Assume exposure is zero in rest breaks 10301045, 12451330 & 15301545

    8-hr TWA = (0.32 x 2.5) + (0.07 x 2) + (0.2 x 2) + (0.1 x 1.5) + (0 x 1.25)

    8

    = 0.8 + 0.14 + 0.4 + 0.15 + 0

    8

    = 0.19 mg/m3

    TLV STEL

    TLV-STEL is a 15 minute TWA exposure that

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    128/162

    TLV STEL is a 15 minute TWA exposure that

    should not be exceeded at any time during a

    workday, even if the TWA is within TLV- TWA

    TLV STEL (cont)

    Can be exposed continuously for a short period withou

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    129/162

    suffering from: Irritation

    Chronic or irreversible toxic effects

    Dose-rate dependent toxic effects or

    Narcosis sufficient to increase likelihood ofaccident, impaired self rescue, or reduced workefficiency

    TLV STEL (cont)

    Exposures above TLV-TWA up to TWA-STEL

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    130/162

    < 15 minutes

    4 times a day

    60 minutes between successive exposures

    TLV - C

    TLV-C the concentration that should not be exceeded

    during any part of the working exposure

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    131/162

    during any part of the working exposure

    If instantaneous measurements are not available,sampling should be conducted for the minimum

    period of time to detect exposures at or above ceilingvalue

    Excursion Limits

    Excursions limits are applied to TLV-TWAs that do NOT

    have TLV-STELs

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    132/162

    have TLV STELs

    Excursions up to 3 x TLV-TWA - less than 30 min/day

    and NO excursions above 5 x TLV-TWA, providing

    TLV-TWA not exceeded (3 x WEL in UK)

    A process is not considered to be under reasonablecontrol if these levels occur

    Mixtures

    When two or more hazardous substances have a

    similar toxicological effect on the same target system,

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    133/162

    similar toxicological effect on the same target system,

    their combined effect rather than that of either

    individually, should be considered

    Where C1/TLV1 + C2/TLV2++ Cn/TLVn < 1

    the TLV for the mixture should be considered as being

    exceeded

    Additive Effect

    Agent Full shift results

    (TLV-TWA)

    Short term results

    (TLV-STEL)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    134/162

    Acetone 160 ppm

    (500)

    490 ppm

    (750)

    Sec butyl acetate 20 ppm

    (200)

    150 ppm

    (N/A)

    Methyl ethyl ketone 90 ppm

    (200)

    220 ppm

    (320)

    From the TLV basics column, the Documentation of the TLVsand BEIs all three substances indicate effects on respiratory

    system and would be considered additive

    Additive Effect (cont)

    Full shift calculation

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    135/162

    C1/TLV1 + C2/TLV2++ Cn/TLVn 1

    therefore 160/500 + 20/200 + 90/200

    = 0.32 + 0.10 + 0.45

    = 0.87

    Hence full shift additive limit not exceeded

    Additive Effect (cont)

    Short term calculation

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    136/162

    = 490/750 + 150/(200 x 5)* + 220/300

    = 0.65 + 0.15 + 0.73

    = 1.53

    This is >1 hence short term additive limitexceeded

    * where no STEL exists the convention is tomultiply TWA exposure standard x 5 (x 3 in UK)

    Units of Measure

    Dusts

    3

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    137/162

    mg/m

    Gases and vapours

    parts per million (ppm) or % (v/v)

    mg/m3

    Conversion of ppm to mg/m3

    Conc in mg/m3 = Conc in ppm x molecular weight /24.45

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    138/162

    where 24.45 = molar volume of air in litres at NTPconditions (25C and 1 atm)

    (NB IUPAC use 0C and 100 kPa, but ACGIH and otherbodies use 25C and 1 atmosphere)

    Conversion of ppm to mg/m3 (cont)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    139/162

    Where STP conditions are required (i.e. 20C not25C) the equation is:

    Conc. in mg/m3 = Conc. in ppm x molecular weight24.06

    Definitions & Notations

    Carcinogenicity

    A carcinogen is an agent capable of inducing benign

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    140/162

    or malignant neoplasms

    A1 - Confirmed human carcinogen

    A2 - Suspected human carcinogen

    A3 - Confirmed animal carcinogen with unknownrelevance to humans

    A4 - Not classifiable as a human carcinogen

    A5 - Not suspected as a human carcinogen

    Definition & Notations (cont)

    Notice of Intended Change (NIC)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    141/162

    Each year proposed changes are indicatedcomments are sought and suggestions for othersubstances to be added are also sought

    Particulate matter / particle size

    For solid and liquid matter, TLVs are expressedas total particulate matter except where terms

    such as inhalable, thoracic or respirable particulatmass are used

    Definition & Notations (cont)

    TLV Basis/Critical Effects

    Is discussed in each documentation.

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    142/162

    The column comments are intended to provide fieldreference for symptoms of over exposure and for whichcompounds may be considered as acting independently oradditively

    Biological Exposure Indices BEIs Listed when a BEI is recommended

    Two sub categories added

    BEIA = see the BEI for Acetylcholinesterase inhibiting pesticide

    BEIM

    = see the BEI for Methemoglobin inducers

    Definitions & Notations (cont)

    Sen potential for agent to produce sensitisation.

    Does not imply that it is the critical effect

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    143/162

    Respiratory

    Dermal

    Conjunctival

    Skin where potential significant contribution to theoverall exposure by the cutaneous route by direct

    contact with the vapour or direct contact with the skin

    Application of Standards

    Airborne concentrations are representative of workers

    exposure:

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    144/162

    Collected in the breathing zone

    Occupational or personal sampling

    Note: If para-occupational or static or area samplingcarried out results should not be compared directly

    with exposure standards

    Extended Work Shifts

    TLVs developed for conventional 8-hour workday

    followed by a 16-hour break from the exposure over a

    40 h k

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    145/162

    40-hour week

    Number of models used to adjust TWA for unusual &extended shifts

    Not necessary to adjust TWA-STEL or TWA-C asthese associated with acute rather than chronicexposures

    Brief & Scala Model

    Reduces OEL proportionally for increased

    exposure & reduced recovery time

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    146/162

    Adjusted OEL = 8 x (24 h) x TWA

    16 x h

    where h = hours worked each day

    Brief & Scala Model (cont)

    Example: Toluene, 12 hour shift, 8 hr TWA is 50 ppm

    Adj t d OEL 8 (24 12) 50

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    147/162

    Adjusted OEL = 8 x (24 12) x 50 ppm

    16 x 12

    = 25 ppm

    NB Brief & Scala model developed for petroleum

    industry & has not been validated for dust exposures

    OSHA Model

    Previously, OSHA used reduced PELs.

    Example: If 10 hour shift being worked,

    TWA (10H ) TWA (8 h ) (8/10)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    148/162

    TWA (10Hr) = TWA (8 hour) x (8/10)

    Now, OSHA official must measure the worst 8-hour

    period and compare result with 8-hour TWA

    Only lead has a exposure reduction

    Lead PEL = 4000g/m3 / shift hours

    OSHA Model - example

    Toluene, 12 hour shift, 8 hr TWA is 50 ppm

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    149/162

    OEL = 50 x 8

    12

    = 33 ppm

    Note difference between Brief & Scala v OSHA models

    with same data

    Pharmacokinetic ModelModel of Hickey & Reist considers metabolism,

    biotransformation and excretion

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    150/162

    Modified TLV = TLV x 1-e-8k 1-e-120k

    1-e-t1k 1-e-t2k

    where t1 = hrs worked per day on usual schedulet2 = 24 x days worked/week on unusual schedule

    k = ln2/t1/2

    This model beyond scope of this course

    WA Department of Minerals & Energy

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    151/162

    Source; DOCEP-reproduced with permission

    Limitations of Hygiene Standards

    Values do not exist for all substances

    Apply to the workforce workers healthier than

    general public

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    152/162

    general public Not meant to apply to general population

    Not for environment or boundary emissionstandards

    Not for use with a set safety factor eg divide by 100

    Not a fine line between safe and dangerousconcentrations

    For use by trained occupational hygienists

    Standards in Other Countries

    AustraliaExposure Standards

    Based on ACGIH List with reference to standards from

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    153/162

    Based on ACGIH List with reference to standards fromGermany, Sweden & UK

    www.ascc.gov.au

    Data base exists for 696 current national exposure

    standards TWA, STEL, peak, carcinogen, Sen, Skin

    Standards in Other Countries (cont)

    United Kingdom Workplace Exposure Limits

    WELs replaced previous Occupational Exposure Limits

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    154/162

    WELs replaced previous Occupational Exposure Limits(OELs) and Maximum Exposure Limits (MELs)

    HSE EH40/2005 (Workplace Exposure Limits) list ofassigned substances

    8-hr TWA & STEL Comments Column containing Safety & Risk Phrases plus

    the Carcinogenicity, Skin, Sensitivity and BiologicalMonitoring Guidance Value notations

    Standards in Other Countries (cont)

    European Limits

    Indicative Occupational Exposure Limit Values IOELV

    Chemical Agents Directive

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    155/162

    Chemical Agents Directive

    Health based

    63 substances

    8-hr TWA, STEL, skin

    Binding Limit Values BLVs

    Carcinogen Directive

    Also reflect socio-economic & tech feasibility factors

    Benzene, hardwood dust, vinyl chloride monomer, lead

    Standards in Other Countries (cont)

    USA OSHA Permitted Exposure Levels (PELs)

    Based on 1968 TLVs - approx 400

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    156/162

    Based on 1968 TLVs - approx 400 Listed updated in 1989

    Number of detailed regulatory requirements

    eg asbestos, lead, benzene, methylene chloride, vinylchloride etc

    Contained in Title 29 of US Code of Federal Regulations

    Standards in Other Countries (cont)

    USA NIOSH Recommended Exposure Limits REL

    NIOSH recommends Standards to OSHA / MSHA (Mine

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    157/162

    NIOSH recommends Standards to OSHA / MSHA (MineSafety & Health Administration) & some are lower thanPELs, TLVs etc

    TWA up to 10-hr day, 40 hour week

    Also STEL, C and Ca, skin Available on CD-ROM or website www.cdc.niosh.gov

    Pocket Guide to Chemical Hazards

    NIOSH Recommendations

    Criteria documents etc

    Standards in Other Countries (cont)

    USA AIHA Workplace Environmental ExposureLevels (WEELs)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    158/162

    Intended to provide guidance where NO legal orauthoritative limit exists

    eg benzyl alcohol, butylene oxide

    In current Guide > 100 WEELs 8-hr TWA, Ceiling, Short Term TWA plus Skin, Dermal &

    Respiratory sensitiser notations

    Standards in Other Countries (cont)

    Germany MAK Commission

    MAK values for volatile chemicals & dusts

    BAT values (biological tolerance values)

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    159/162

    BAT values (biological tolerance values)

    Analytical procedures (air & biological materials)

    Notations for carcinogens, germ cell mutagenic,

    sensitizing, percutaneously absorbed & embryoniceffects

    Published & reviewed annually

    Review of Todays Learning Outcomes

    Physiology & toxicology

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    160/162

    Understand and be aware of the features of theinteracting systems of the human body

    Understand the routes of contaminant entry into

    the human body and their target organs andsystems

    Understand the concept of dose response

    Review of Todays Learning Outcomes (cont

    Risk Assessment

    Understand principles & processes of risk

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    161/162

    Understand principles & processes of riskassessment

    Be able to apply these principles & processes in aworkplace situation

    Review of Todays Learning Outcomes (cont

    Hygiene standards

  • 7/30/2019 JA36 v1-0 13Apr10 W501 Final Slides Day 1

    162/162

    Understand the principles of setting hygienestandards

    Understand the application and limitations ofhygiene standards